Hemovigilance

The main activities of the Hemovigilance are:

• Traceability of labile blood products prescribed to patients at the University Hospital,
• The analysis and reporting to theANSM of adverse effects (unexpected or undesirable events occurring during or following a transfusion) and incidents in the transfusion chain,
• Information and training on "Transfusion" for relevant professionals, including nurses, doctors, interns, midwives, and those responsible for transporting labile blood products…
• Transfusion investigations,
• Participation in the University Hospital's Quality initiatives, with the aim of continuously strengthening transfusion safety, with the professionals involved.